MORE THAN 300 politicians, health experts and celebrities yesterday called for US pharmaceutical giant Gilead to allow cheap, generic versions of a promising new HIV drug to be produced, so it can reach people in developing countries most affected by the deadly disease. The drug Lenacapavir could be a “real game-changer” in the fight against HIV, according to an open letter to Gilead CEO Daniel O’Day signed by a range of former world leaders, Aids groups, activists, actors and others. Lenacapavir, which was approved for use in the US and the EU in 2022, only needs to be injected twice a year, making it particularly suited for people normally “excluded from high-quality health care”, the open letter said. “We urge Gilead to ensure that people in the Global South living…